Showing results (211-220 of 239) with videos related to

Sort By:
Pageof 24
Biomed Research International|October 29, 2015
A Media and Clinic Intervention to Increase Colorectal Cancer Screening in Ohio AppalachiaJessica L Krok-Schoen, Mira L Katz, Jill M Oliveri, et al.
PLOS Global Public Health|October 19, 2023
Common patterns between dengue cases, climate, and local environmental variables in Costa Rica: A wavelet approachYury E García, Shu Wei Chou-Chen, Luis A Barboza, et al.
Preventing Chronic Disease|December 7, 2023
Mail-Based Self-Sampling to Complete Colorectal Cancer Screening: Accelerating Colorectal Cancer Screening and Follow-up Through Implementation ScienceSamir Gupta, Autumn Barnes, Alison T Brenner, et al.
Magnetic Resonance in Chemistry : MRC|April 1, 2011
NMR assignment in regioisomeric hydroquinonesJose A Dobado, José C Gómez-Tamayo, Francisco G Calvo-Flores, et al.
EMBO Molecular Medicine|November 11, 2021
Live imaging of neolymphangiogenesis identifies acute antimetastatic roles of dsRNA mimicsDavid Olmeda, Daniela Cerezo-Wallis, Cynthia Mucientes, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|March 7, 2002
The use of placebo-controlled and non-inferiority trials for the evaluation of new drugs in the treatment of postmenopausal osteoporosisP D Delmas, G Calvo, M Boers, et al.
Oncotarget|May 27, 2015
RAB7 counteracts PI3K-driven macropinocytosis activated at early stages of melanoma developmentDirena Alonso-Curbelo, Lisa Osterloh, Estela Cañón, et al.
Cancer|October 20, 2020
Health-related quality of life outcomes for the LEAP study-CALGB 70305 (Alliance): A lymphedema prevention intervention trial for newly diagnosed breast cancer patientsMichelle J Naughton, Heshan Liu, Drew K Seisler, et al.
Cancer|October 20, 2020
A randomized study to prevent lymphedema in women treated for breast cancer: CALGB 70305 (Alliance)Electra D Paskett, Jennifer Le-Rademacher, Jill M Oliveri, et al.
HIV Medicine|January 22, 2003
Modelling the 3-year risk of myocardial infarction among participants in the Data Collection on Adverse Events of Anti-HIV Drugs (DAD) studyM Law, N Friis-Møller, R Weber, et al.
Pageof 24